[Health democracy: Patient partnership].

Démocratie sanitaire : le patient partenaire de sa prise en charge.
Décision partagée Ethics Oncologie radiothérapie Patient partenaire Patient partnership Radiation oncology Security Shared decision Sécurité Éthique

Journal

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
ISSN: 1769-6658
Titre abrégé: Cancer Radiother
Pays: France
ID NLM: 9711272

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 24 05 2020
revised: 26 06 2020
accepted: 27 06 2020
pubmed: 31 8 2020
medline: 9 10 2020
entrez: 31 8 2020
Statut: ppublish

Résumé

In 2019, the scientific committee of the French society of radiation oncology (SFRO) created an ethics committee. Its mission is to provide our professional community with food for thought on ethical issues, and to identify its specificities within the radiation oncology departments. For the 2020 annual conference, the commission looked into the evolution of the patient-carer relationship, and more particularly to the strong idea of patient partnership. Indeed, the writing of the White Book of Cancer gave voice to sick people and stressed the need for new devices, such as the Caregiving Time. Patients can no longer be considered as objects of care but as people whose dignity and autonomy must be imperatively respected. The acquisition of knowledge allows a bilateral exchange, prerequisite of a dynamic collaboration. Patients can be partners in their own care, partners in training and research (expert patient), but also partners in health institutions and policies. It is this notion of partnership and involvement of the person in their path of care in radiation oncology that we will analyse here. It will be about defining it, by developing the concept of autonomy, and bringing out its complexity and ambivalence through two examples from our clinical practice: the shared decision-making process for patients with localized prostate cancer and the patient's involvement in the success of his radiotherapy.

Identifiants

pubmed: 32861610
pii: S1278-3218(20)30196-7
doi: 10.1016/j.canrad.2020.06.021
pii:
doi:

Types de publication

Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

736-743

Informations de copyright

Copyright © 2020 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

Auteurs

T Haaser (T)

Service de radiothérapie, hôpital Haut-Lévêque, centre hospitalier universitaire de Bordeaux, Pessac, France. Electronic address: thibaud.haaser@chu-bordeaux.fr.

Y Constantinidès (Y)

Espace éthique Île-de-France, Paris Université Sorbonne Nouvelle, Paris, France.

C Dejean (C)

Service de radiothérapie, unité de physique médicale, centre Antoine-Lacassagne, Nice, France.

A Escande (A)

Service universitaire de radiothérapie, laboratoire CRIStAL, UMR9189, centre Oscar-Lambret, faculté de médecine Henri-Warembourg, université de Lille, Lille, France.

P Le Tallec (P)

Service de radiothérapie, Quantis Litis EA 4108, centre Henri-Becquerel, Rouen, France.

F Lorchel (F)

Centre de radiothérapie et oncologie de Mâcon - Orlam, Mâcon, France; Service de radiothérapie, centre hospitalier universitaire Lyon-Sud, Lyon, France.

S Marty (S)

Centre de coordination en cancérologie, centre hospitalier universitaire de Bordeaux, Pessac, France.

S Thureau (S)

Service de radiothérapie, Quantis Litis EA 4108, centre Henri-Becquerel, Rouen, France.

F Huguet (F)

Service d'oncologie radiothérapie, centre de recherche Saint-Antoine UMR_S 938, Sorbonne université, hôpital Tenon, institut universitaire de cancérologie, AP-HP, Paris, France.

J-L Lagrange (JL)

Université Paris-Est Créteil Val-de-Marne, Paris, France.
Service de radiothérapie, hôpital Haut-Lévêque, centre hospitalier universitaire de Bordeaux, Pessac, France; Espace éthique Île-de-France, Paris Université Sorbonne Nouvelle, Paris, France; Service de radiothérapie, unité de physique médicale, centre Antoine-Lacassagne, Nice, France; Service universitaire de radiothérapie, laboratoire CRIStAL, UMR9189, centre Oscar-Lambret, faculté de médecine Henri-Warembourg, université de Lille, Lille, France; Service de radiothérapie, Quantis Litis EA 4108, centre Henri-Becquerel, Rouen, France; Centre de radiothérapie et oncologie de Mâcon - Orlam, Mâcon, France; Service de radiothérapie, centre hospitalier universitaire Lyon-Sud, Lyon, France; Centre de coordination en cancérologie, centre hospitalier universitaire de Bordeaux, Pessac, France; Service d'oncologie radiothérapie, centre de recherche Saint-Antoine UMR_S 938, Sorbonne université, hôpital Tenon, institut universitaire de cancérologie, AP-HP, Paris, France; Université Paris-Est Créteil Val-de-Marne, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH